JAZZ Annual CFF
-$305.25 M
+$224.24 M+42.35%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual cash flow from financing activities is -$305.25 million, with the most recent change of +$224.24 million (+42.35%) on December 31, 2023. During the last 3 years, it has fallen by -$833.33 million (-157.81%). JAZZ annual CFF is now -107.69% below its all-time high of $3.97 billion, reached on December 31, 2021.JAZZ Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly CFF
$246.43 M
+$407.51 M+252.98%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly cash flow from financing activities is $246.43 million, with the most recent change of +$407.51 million (+252.98%) on September 30, 2024. Over the past year, it has increased by +$324.92 million (+413.95%). JAZZ quarterly CFF is now -94.72% below its all-time high of $4.66 billion, reached on June 30, 2021.JAZZ Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ TTM CFF
-$71.52 M
+$324.92 M+81.96%
30 September 2024
Summary:
As of January 22, 2025, JAZZ TTM cash flow from financing activities is -$71.52 million, with the most recent change of +$324.92 million (+81.96%) on September 30, 2024. Over the past year, it has increased by +$113.84 million (+61.42%). JAZZ TTM CFF is now -101.52% below its all-time high of $4.72 billion, reached on June 30, 2021.JAZZ TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.4% | +413.9% | +61.4% |
| 3 y3 years | -157.8% | +413.9% | +61.4% |
| 5 y5 years | +36.3% | +413.9% | +61.4% |
JAZZ Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.7% | +42.4% | at high | +185.3% | -101.8% | +92.6% |
| 5 y | 5-year | -107.7% | +42.4% | -94.7% | +153.0% | -101.5% | +92.6% |
| alltime | all time | -107.7% | +42.4% | -94.7% | +153.0% | -101.5% | +92.6% |
Jazz Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $246.43 M(-253.0%) | -$71.52 M(-82.0%) |
| June 2024 | - | -$161.09 M(+184.8%) | -$396.44 M(+19.4%) |
| Mar 2024 | - | -$56.55 M(-43.6%) | -$332.02 M(+8.8%) |
| Dec 2023 | -$305.25 M(-42.3%) | -$100.31 M(+27.8%) | -$305.25 M(+64.7%) |
| Sept 2023 | - | -$78.49 M(-18.8%) | -$185.35 M(-53.2%) |
| June 2023 | - | -$96.67 M(+224.5%) | -$395.91 M(+37.2%) |
| Mar 2023 | - | -$29.79 M(-252.0%) | -$288.47 M(-45.5%) |
| Dec 2022 | -$529.49 M(-113.3%) | $19.60 M(-106.8%) | -$529.49 M(-33.5%) |
| Sept 2022 | - | -$289.05 M(-2782.1%) | -$795.70 M(-18.1%) |
| June 2022 | - | $10.78 M(-104.0%) | -$971.82 M(-126.4%) |
| Mar 2022 | - | -$270.81 M(+9.8%) | $3.68 B(-7.3%) |
| Dec 2021 | $3.97 B(+651.9%) | -$246.61 M(-47.0%) | $3.97 B(-7.1%) |
| Sept 2021 | - | -$465.18 M(-110.0%) | $4.27 B(-9.4%) |
| June 2021 | - | $4.66 B(>+9900.0%) | $4.72 B(+579.4%) |
| Mar 2021 | - | $18.28 M(-67.3%) | $694.03 M(+31.4%) |
| Dec 2020 | $528.07 M(-279.8%) | $55.88 M(-346.6%) | $528.07 M(+37.4%) |
| Sept 2020 | - | -$22.66 M(-103.5%) | $384.42 M(-0.8%) |
| June 2020 | - | $642.53 M(-535.1%) | $387.61 M(-224.6%) |
| Mar 2020 | - | -$147.68 M(+68.2%) | -$311.08 M(+5.9%) |
| Dec 2019 | -$293.75 M(-38.7%) | -$87.78 M(+351.0%) | -$293.75 M(-55.0%) |
| Sept 2019 | - | -$19.46 M(-65.3%) | -$652.42 M(+0.8%) |
| June 2019 | - | -$56.15 M(-56.9%) | -$646.93 M(+15.1%) |
| Mar 2019 | - | -$130.35 M(-70.8%) | -$561.90 M(+17.3%) |
| Dec 2018 | -$479.13 M(+17.1%) | -$446.46 M(+3095.4%) | -$479.13 M(+559.4%) |
| Sept 2018 | - | -$13.97 M(-148.4%) | -$72.66 M(+129.5%) |
| June 2018 | - | $28.87 M(-160.7%) | -$31.66 M(-88.5%) |
| Mar 2018 | - | -$47.58 M(+19.0%) | -$275.01 M(-32.8%) |
| Dec 2017 | -$409.11 M(-175.6%) | -$39.98 M(-247.9%) | -$409.11 M(-24.4%) |
| Sept 2017 | - | $27.03 M(-112.6%) | -$541.17 M(-265.5%) |
| June 2017 | - | -$214.48 M(+18.1%) | $327.02 M(-36.1%) |
| Mar 2017 | - | -$181.67 M(+5.6%) | $511.77 M(-5.4%) |
| Dec 2016 | $540.99 M(-352.4%) | -$172.04 M(-119.2%) | $540.99 M(-8.2%) |
| Sept 2016 | - | $895.23 M(-3110.7%) | $589.17 M(-247.1%) |
| June 2016 | - | -$29.73 M(-80.5%) | -$400.48 M(+10.2%) |
| Mar 2016 | - | -$152.46 M(+23.1%) | -$363.52 M(+69.6%) |
| Dec 2015 | -$214.32 M | -$123.86 M(+31.2%) | -$214.32 M(+112.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | -$94.42 M(-1407.3%) | -$100.90 M(-139.3%) |
| June 2015 | - | $7.22 M(-321.5%) | $256.79 M(+22.2%) |
| Mar 2015 | - | -$3.26 M(-68.8%) | $210.11 M(-70.4%) |
| Dec 2014 | $711.03 M(-3080.5%) | -$10.44 M(-104.0%) | $711.03 M(+2.6%) |
| Sept 2014 | - | $263.27 M(-767.3%) | $692.75 M(+80.5%) |
| June 2014 | - | -$39.45 M(-107.9%) | $383.76 M(-18.5%) |
| Mar 2014 | - | $497.66 M(-1832.6%) | $470.67 M(-2073.0%) |
| Dec 2013 | -$23.86 M(-105.3%) | -$28.72 M(-37.2%) | -$23.86 M(-382.1%) |
| Sept 2013 | - | -$45.72 M(-196.3%) | $8.46 M(-82.6%) |
| June 2013 | - | $47.46 M(+1414.7%) | $48.69 M(-89.6%) |
| Mar 2013 | - | $3.13 M(-12.7%) | $469.89 M(+4.8%) |
| Dec 2012 | $448.53 M(-1455.8%) | $3.59 M(-165.4%) | $448.53 M(+0.2%) |
| Sept 2012 | - | -$5.49 M(-101.2%) | $447.74 M(+6.7%) |
| June 2012 | - | $468.65 M(-2671.5%) | $419.62 M(-968.5%) |
| Mar 2012 | - | -$18.23 M(-750.7%) | -$48.32 M(+46.1%) |
| Dec 2011 | -$33.08 M(+20.2%) | $2.80 M(-108.3%) | -$33.08 M(-7.1%) |
| Sept 2011 | - | -$33.61 M(-4774.8%) | -$35.62 M(+455.8%) |
| June 2011 | - | $719.00 K(-124.0%) | -$6.41 M(-75.8%) |
| Mar 2011 | - | -$2.99 M(-1236.9%) | -$26.47 M(-3.8%) |
| Dec 2010 | -$27.53 M(-316.8%) | $263.00 K(-106.0%) | -$27.53 M(+30.1%) |
| Sept 2010 | - | -$4.40 M(-77.2%) | -$21.15 M(+204.5%) |
| June 2010 | - | -$19.34 M(+377.8%) | -$6.95 M(-155.5%) |
| Mar 2010 | - | -$4.05 M(-161.0%) | $12.52 M(-1.4%) |
| Dec 2009 | $12.69 M(-80.2%) | $6.64 M(-32.3%) | $12.69 M(+85.8%) |
| Sept 2009 | - | $9.80 M(+7620.5%) | $6.83 M(-62.5%) |
| June 2009 | - | $127.00 K(-103.3%) | $18.20 M(-14.7%) |
| Mar 2009 | - | -$3.88 M(-599.4%) | $21.33 M(-66.7%) |
| Dec 2008 | $64.13 M(-35.7%) | $776.00 K(-96.3%) | $64.13 M(-1.3%) |
| Sept 2008 | - | $21.17 M(+549.7%) | $64.98 M(+52.5%) |
| June 2008 | - | $3.26 M(-91.6%) | $42.62 M(-69.0%) |
| Mar 2008 | - | $38.92 M(+2289.4%) | $137.69 M(+38.0%) |
| Dec 2007 | $99.75 M(-14.9%) | $1.63 M(-237.2%) | $99.75 M(+1.7%) |
| Sept 2007 | - | -$1.19 M(-101.2%) | $98.12 M(-1.2%) |
| June 2007 | - | $98.32 M(+9841.4%) | $99.31 M(>+9900.0%) |
| Mar 2007 | - | $989.00 K | $989.00 K |
| Dec 2006 | $117.19 M(-39.2%) | - | - |
| Dec 2005 | $192.85 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual CFF year-on-year change?
- What is Jazz Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly CFF year-on-year change?
- What is Jazz Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM CFF year-on-year change?
What is Jazz Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of JAZZ is -$305.25 M
What is the all time high annual CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual cash flow from financing activities is $3.97 B
What is Jazz Pharmaceuticals annual CFF year-on-year change?
Over the past year, JAZZ annual cash flow from financing activities has changed by +$224.24 M (+42.35%)
What is Jazz Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of JAZZ is $246.43 M
What is the all time high quarterly CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly cash flow from financing activities is $4.66 B
What is Jazz Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, JAZZ quarterly cash flow from financing activities has changed by +$324.92 M (+413.95%)
What is Jazz Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of JAZZ is -$71.52 M
What is the all time high TTM CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM cash flow from financing activities is $4.72 B
What is Jazz Pharmaceuticals TTM CFF year-on-year change?
Over the past year, JAZZ TTM cash flow from financing activities has changed by +$113.84 M (+61.42%)